The global pneumonia diagnostics market is expected to enjoy a valuation of USD 521.1 Million by the end of 2022, and further expand at a CAGR of 5.6% from 2022 to 2032, reaching a valuation of USD 899.4 Million by 2032. The rising prevalence of pneumonia along with the growing need for early detection of this medical condition for initiating a proper treatment is a key factor driving demand for pneumonia diagnostics in the market.
Based on product, the streptococcus-based segment dominated the global pneumonia diagnostics market with a share of about 36.2% in 2021 and the trend is likely to continue during the assessment period. The overall pneumonia diagnostics market constituted approximately 0.6% of the global in vitro diagnostics market which stood at USD 76.3 Billion in 2021.
| Attribute | Key Insights |
|---|---|
| Pneumonia Diagnostics Market Base Value (2021) | USD 492.2 Million |
| Estimated Market Value (2022) | USD 521.1 Million |
| Projected Market Value (2032) | USD 899.4 Million |
| Value-based CAGR (2022 to 2032) | 5.6% |
| Market Share of Top 5 Countries | 43.9% |
Pneumonia continues to be a worldwide health concern with a high morbidity and fatality rate. Identifying the microbial pathogens that cause lung infection is crucial for optimal clinical care of pneumonia patients and is a significant barrier to conventional microbiological approaches.
In recent years, the discovery and deployment of molecular diagnostic assays for pneumonia have resulted in a significant improvement in the microbiological detection of respiratory pathogens. However, with new information about the microbiome and lungs presenting a dynamic microbiological ecosystem, our present notion of pneumonia is no longer completely practical, because this new idea of pneumonia entails modification of the lung microbiome.
Pneumonia diagnostics refers to solutions used to identify and detect pneumonia-causing agents like streptococcus, legionella, chlamydophilla, mycoplasma, etc. They are being increasingly utilized to detect pneumonia, especially during its early stages, to initiate a proper treatment approach.
Growing focus on reducing the mortality rate of pneumonia will therefore continue to boost the global pneumonia diagnostics market during the forecast period.
Similarly, increasing health awareness and availability of advanced diagnostic products will further accelerate growth in the market during the assessment period.
Regionally, North America held the highest market share of 30.6% in 2021 and it is likely to retain its dominance during the forecast period. Factors such as the increasing incidence of infectious diseases, the presence of leading manufacturers, and the availability of advanced products are propelling sales in the USA market.
The overall sales in the pneumonia diagnostics market are projected to grow at 5.6% CAGR between 2022 and 2032, in comparison to the 4.5% CAGR registered from 2012 to 2021.
The rising incidence of pneumonia, the growing focus on early detection of infectious diseases, and advancements in diagnostics techniques are some of the key factors driving the global pneumonia diagnostic market.
Lung infections and other infectious diseases are becoming more common, there is an increase in the demand for diagnostics for pneumonia. One type of acute lung infection is pneumonia. A healthy person's lungs are made up of tiny sacs called alveoli that are filled with air as they breathe. Pneumonia causes the alveoli to bloat up with pus and fluid, which makes breathing challenging and limits oxygen intake.
The most common infectious cause of death in children worldwide is pneumonia. According to the World Health Organization 2021, pneumonia caused 740 to 180 deaths below the age of five in 2019, contributing to 14% of all deaths in children under the age of five but 22% of all deaths in children aged 1 to 5. Pneumonia affects children and families worldwide, although mortality is highest in Sub-Saharan Africa and South Asia.
The increasing adoption of point-of-care diagnostics and development in the detection of nucleic acid around the globe are set to boost the market in the given forecast period.
These factors, combined with the growing tendency toward preventive care are projected to increase the demand for pneumonia diagnostics products over the forecast period.
Rising Government Initiatives and Advancements in Diagnostic Technologies to Boost Market Over the Next Decade
The global pneumonia diagnostics market is likely to witness healthy growth owing to the increasing investments and initiatives by governments in emerging countries to modernize healthcare infrastructure.
The broad availability of rapid molecular diagnostic testing offers an unprecedented insight into pneumonia etiologies, challenging paradigms established by previous investigations from microbiological cultures.
Microscopy and culture of blood cultures, respiratory tract specimens, detection of antigens in urine and respiratory specimens, and detection of specific antibodies in the blood continue to be used in the routine laboratory evaluation of patients with pneumonia (serology). Nucleic acid detection technologies, such as polymerase chain reaction (PCR), have been available for more than two decades and are now commonplace in tertiary-level diagnostic laboratories.
Advancements in current diagnostics and innovation will thrive in the market in near future. For instance, Massachusetts Institute of Technology researchers have developed a sensor that can differentiate between viral and bacterial pneumonia infections, which they hope may aid doctors in selecting the best therapy.
The pricing pressure due to competition and difficulty in diagnosing can hamper the growth of the pneumonia diagnostics market during the forecast period.
In the community environment, the diagnosis and management of pneumonia usually become extremely complex. Physician approaches are primarily dependent on diagnosis information. In some circumstances, false positive results result in catastrophic patient mismanagement with antibiotics, as well as the possibility of superinfection and medication complications.
Immunoassay approaches for diagnosis are promising, however, they are still insufficient to screen for a wide range of pathogens. All these factors act as restraints in the growth of the pneumonia diagnostics market.
Similarly, low healthcare awareness across lower economies along with inadequate reimbursement policies is emerging as a significant impediment to the development of the pneumonia diagnostics market.
Increasing Incidence of Pneumonia and High Diagnostic Rates Driving Market in the USA
The USA dominated the North American pneumonia diagnostics market with a total market share of about 84.0% in 2021 and it is likely to expand at a steady pace during the forecast period.
Growth in the USA pneumonia diagnostics market is driven by the rising prevalence of pneumonia, increasing diagnostic screening rates due to high levels of awareness among people, and the presence of leading manufacturers.
Over the years, there has been a significant rise in the cases of pneumonia and pneumonia-related deaths across the USA which has necessitated the adoption of pneumonia diagnostics.
For instance, as per the Centers for Disease Control and Prevention (CDC), around 25.5% of USA adults suffered from pneumonia in 2020 while the total number of pneumonia-related deaths reached 47,601. In order to tackle this, people opt for various diagnostic tests and treatments. This will continue to boost the pneumonia diagnostics market in the country during the next ten years.
Similarly, increasing healthcare care spending and the presence of favourable reimbursement policies will further boost the demand for pneumonia diagnostic products in the USA market over the assessment period.
Easy Availability of Pneumonia Diagnostics Products Fuelling Sales in Canada
Canada held approximately 16.0% share in the North American pneumonia diagnostics market in 2021 and it is projected to display a growth rate of around 6.3% CAGR during the forecast period.
Growth in Canada’s pneumonia diagnostics market is projected to be driven by increasing production of pneumonia diagnostics products by top players, surging cases of pneumonia infection, and rising health awareness among people.
Favourable government support and the availability of better treatment approaches will further boost the market in the country over the next decade.
Continuous Advancements in Diagnostics Technologies to Boost Market in Germany
As per FMI, the overall pneumonia diagnostics market in Germany is set to exhibit a CAGR of nearly 7.5% during the forecast period (2022 to 2032). Germany is becoming increasingly popular when it comes to health and innovation.
With the increasing prevalence of chronic diseases and rising geriatric population demand for pneumonia diagnostics products will grow at a robust pace across Germany during the forecast period.
Similarly, the flourishing medical tourism sector and advancements in diagnostic technology will bode well for Germany’s pneumonia diagnostics market over the next ten years.
Demand to Remain High for Streptococcus-Based Diagnostic Products
As per FMI, the streptococcus-based diagnostic products segment held the largest market share of about 36.2% in 2021 and it is expected to grow at a CAGR of 5.6% throughout the forecast period. This can be attributed to the rising prevalence of pneumococcal diseases and the increasing usage of streptococci-based diagnostic products for detecting this disease.
Streptococci are typically cultured on blood-supplemented agar media. This approach detects haemolysis, which is necessary for further identification procedures, and increases streptococci growth by introducing an external supply of catalase. Since this strain is the most common cause of pneumonia, this segment is set to drive the growth of the overall market.
With several competitors in the pneumonia diagnostics production sphere, the overall market is fragmented. To meet consumer demand and expand their customer base, these companies are implementing methods such as mergers and acquisitions, partnerships and collaborations, and new product launches.
Instances of key developmental strategies by the industry players in the pneumonia diagnostics market are given below:
| Attribute | Details |
|---|---|
| Estimated Market Size (2022) | USD 521.1 Million |
| Projected Market Size (2032) | USD 899.4 Million |
| Anticipated Growth Rate (2022 to 2032) | 5.6% |
| Forecast Period | 2012 to 2021 |
| Historical Data Available for | 2022 to 2032 |
| Market Analysis | USD Million for Value |
| Key Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; and Middle East & Africa |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, UK, Germany, Italy, Russia, Spain, France, BENELUX, Nordic Countries, India, Thailand, Indonesia, Malaysia, Philippines, Vietnam, Japan, China, South Korea, Australia, New Zealand, Israel, Turkey, GCC Countries, and South Africa |
| Key Market Segments Covered | Product and Region |
| Key Companies Profiled | Thermo Fisher Scientific Inc.; Alere Inc.; Quidel Corporation; Becton, Dickinson, and Company; Meridian Bioscience, Inc; Qiagen N.V.; bioMérieux SA; Bio-Rad Laboratories Inc.; Cardinal Health Inc.; Beckman Coulter Inc (DanaherCorporation); Hologic Inc.; La Roche Ltd.; Abbot Laboratories; Quest Diagnostics; Luminex Corporation |
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, Drivers, Restraints, Opportunities and Threats Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
Table 01: Global Market Value (US$ Million) Analysis 2012 to 2021, By Product
Table 02: Global Market Value (US$ Million) Forecast 2022 to 2032, By Product
Table 03: Global Market Value (US$ Million) Analysis 2012 to 2021, By Region
Table 04: Global Market Value (US$ Million) Forecast 2022 to 2032, By Region
Table 05: North America Market Value (US$ Million) Analysis 2012 to 2021, By Country
Table 06: North America Market Value (US$ Million) Forecast 2022 to 2032, By Country
Table 07: North America Market Value (US$ Million) Analysis 2012 to 2021, By Product
Table 08: North America Market Value (US$ Million) Forecast 2022 to 2032, By Product
Table 09: North America Market Value (US$ Million) Analysis 2012 to 2021, By Product
Table 10: North America Market Value (US$ Million) Forecast 2022 to 2032, By Product
Table 11: Latin America Market Value (US$ Million) Analysis 2012 to 2021, By Country
Table 12: Latin America Market Value (US$ Million) Forecast 2022 to 2032, By Country
Table 13: Latin America Market Value (US$ Million) Analysis 2012 to 2021, By Product
Table 14: Latin America Market Value (US$ Million) Forecast 2022 to 2032, By Product
Table 15: Europe Market Value (US$ Million) Analysis 2012 to 2021, By Country
Table 16: Europe Market Value (US$ Million) Forecast 2022 to 2032, By Country
Table 17: Europe Market Value (US$ Million) Analysis 2012 to 2021, By Product
Table 18: Europe Market Value (US$ Million) Forecast 2022 to 2032, By Product
Table 19: East Asia Market Value (US$ Million) Analysis 2012 to 2021, By Country
Table 20: East Asia Market Value (US$ Million) Forecast 2022 to 2032, By Country
Table 21: East Asia Market Value (US$ Million) Analysis 2012 to 2021, By Product
Table 22: East Asia Market Value (US$ Million) Forecast 2022 to 2032, By Product
Table 23: South Asia Market Value (US$ Million) Analysis 2012 to 2021, By Country
Table 24: South Asia Market Value (US$ Million) Forecast 2022 to 2032, By Country
Table 25: South Asia Market Value (US$ Million) Analysis 2012 to 2021, By Product
Table 26: South Asia Market Value (US$ Million) Forecast 2022 to 2032, By Product
Table 27: Oceania Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 20
Table 28: Oceania Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 20
Table 29: Oceania Market Value (US$ Million) Analysis 2012 to 2021, By Product
Table 30: Oceania Market Value (US$ Million) Forecast 2022 to 2032, By Product
Table 31: Middle East & Africa Market Value (US$ Million) Analysis 2012 to 2021, By Country
Table 32: Middle East & Africa Market Value (US$ Million) Forecast 2022 to 2032, By Country
Table 33: Middle East & Africa Market Value (US$ Million) Analysis 2012 to 2021, By Product
Table 34: Middle East & Africa Market Value (US$ Million) Forecast 2022 to 2032, By Product
Figure 01: Global Market Value, 2012 to 2021
Figure 02: Global Market Value (US$ Million) & Y-o-Y Growth (%), 2022 to 2032
Figure 03: Global Market Absolute $ Opportunity, 2022 to 2032
Figure 04: Global Market Share Analysis (%) by Product, 2022 to 2032
Figure 05: Global Market Y-o-Y Growth Projections By Product, 2022 to 2032
Figure 06: Global Market Attractiveness Analysis, By Product, 2022 to 2032
Figure 07: Global Market Share Analysis (%) by Region 2022 to 2032
Figure 08: Global Market Y-o-Y Growth Projections By Region, 2022 to 2032
Figure 09: Global Market Attractiveness Analysis, By Region, 2022 to 2032
Figure 10: North America Market Share, By Product, 2022 (E)
Figure 11: North America Market Share, By Country, 2022 (E)
Figure 12: North America Market Size (US$ Million) Analysis, 2012 to 2021
Figure 13: North America Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2032
Figure 14: North America Market Attractiveness Analysis, By Product, 2022 to 2032
Figure 15: North America Market Attractiveness Analysis, By Country, 2022 to 2032
Figure 16: USA Market Value Proportion Analysis, 2021
Figure 17: Global Vs USA Y-o-Y Growth Comparison, 2021 to 2032
Figure 18: USA Market Share Analysis (%) by Product, 2021 to 2032
Figure 19: Canada Market Value Proportion Analysis, 2021
Figure 20: Global Vs Canada Y-o-Y Growth Comparison, 2021 to 2032
Figure 21: Canada Market Share Analysis (%) by Product, 2021 to 2032
Figure 22: Latin America Market Share, By Product, 2022 (E)
Figure 23: Latin America Market Share, By Country, 2022 (E)
Figure 24: Latin America Market Size (US$ Million) Analysis, 2012 to 2021
Figure 25: Latin America Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2032
Figure 26: Latin America Market Attractiveness Analysis, By Product, 2022 to 2032
Figure 27: Latin America Market Attractiveness Analysis, By Country, 2022 to 2032
Figure 28: Brazil Market Value Proportion Analysis, 2021
Figure 29: Global Vs Brazil Y-o-Y Growth Comparison, 2021 to 2032
Figure 30: Brazil Market Share Analysis (%) by Product, 2021 to 2032
Figure 31: Mexico Market Value Proportion Analysis, 2021
Figure 32: Global Vs Mexico Y-o-Y Growth Comparison, 2021 to 2032
Figure 33: Mexico Market Share Analysis (%) by Product, 2021 to 2032
Figure 34: Argentina Market Value Proportion Analysis, 2021
Figure 35: Global Vs Argentina Y-o-Y Growth Comparison, 2021 to 2032
Figure 36: Argentina Market Share Analysis (%) by Product, 2021 to 2032
Figure 37: Europe Market Share, By Product, 2022 (E)
Figure 38: Europe Market Share, By Country, 2022 (E)
Figure 39: Europe Market Size (US$ Million) Analysis, 2012 to 2021
Figure 40: Europe Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2032
Figure 41: Europe Market Attractiveness Analysis, By Product, 2022 to 2032
Figure 42: Europe Market Attractiveness Analysis, By Country, 2022 to 2032
Figure 43: Germany Market Value Proportion Analysis, 2021
Figure 44: Global Vs Germany Y-o-Y Growth Comparison, 2021 to 2032
Figure 45: Germany Market Share Analysis (%) by Product, 2021 to 2032
Figure 46: Italy Market Value Proportion Analysis, 2021
Figure 47: Global Vs Italy Y-o-Y Growth Comparison, 2021 to 2032
Figure 48: Italy Market Share Analysis (%) by Product, 2021 to 2032
Figure 49: France Market Value Proportion Analysis, 2021
Figure 50: Global Vs France Y-o-Y Growth Comparison, 2021 to 2032
Figure 51: France Market Share Analysis (%) by Product, 2021 to 2032
Figure 52: UK Market Value Proportion Analysis, 2021
Figure 53: Global Vs UK Y-o-Y Growth Comparison, 2021 to 2032
Figure 54: UK Market Share Analysis (%) by Product, 2021 to 2032
Figure 55: Spain Market Value Proportion Analysis, 2021
Figure 56: Global Vs Spain Y-o-Y Growth Comparison, 2021 to 2032
Figure 57: Spain Market Share Analysis (%) by Product, 2021 to 2032
Figure 58: BENELUX Market Value Proportion Analysis, 2021
Figure 59: Global Vs BENELUX Y-o-Y Growth Comparison, 2021 to 2032
Figure 60: BENELUX Market Share Analysis (%) by Product, 2021 to 2032
Figure 61: Nordic Countries Market Value Proportion Analysis, 2021
Figure 62: Global Vs Nordic Countries Y-o-Y Growth Comparison, 2021 to 2032
Figure 63: Nordic Countries Market Share Analysis (%) by Product, 2021 to 2032
Figure 64: Russia Market Value Proportion Analysis, 2021
Figure 65: Global Vs Russia Y-o-Y Growth Comparison, 2021 to 2032
Figure 66: Russia Market Share Analysis (%) by Product, 2021 to 2032
Figure 67: East Asia Market Share, By Product, 2022 (E)
Figure 68: East Asia Market Share, By Country, 2022 (E)
Figure 69: East Asia Market Size (US$ Million) Analysis, 2012 to 2021
Figure 70: East Asia Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2032
Figure 71: East Asia Market Attractiveness Analysis, By Product, 2022 to 2032
Figure 72: East Asia Market Attractiveness Analysis, By Country, 2022 to 2032
Figure 73: China Market Value Proportion Analysis, 2021
Figure 74: Global Vs China Y-o-Y Growth Comparison, 2021 to 2032
Figure 75: China Market Share Analysis (%) by Product, 2021 to 2032
Figure 76: Japan Market Value Proportion Analysis, 2021
Figure 77: Global Vs Japan Y-o-Y Growth Comparison, 2021 to 2032
Figure 78: Japan Market Share Analysis (%) by Product, 2021 to 2032
Figure 79: South Korea Market Value Proportion Analysis, 2021
Figure 80: Global Vs South Korea Y-o-Y Growth Comparison, 2021 to 2032
Figure 81: South Korea Market Share Analysis (%) by Product, 2021 to 2032
Figure 82: South Asia Market Share, By Product, 2022 (E)
Figure 83: South Asia Market Share, By Country, 2022 (E)
Figure 84: South Asia Market Size (US$ Million) Analysis, 2012 to 2021
Figure 85: South Asia Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2032
Figure 86: South Asia Market Attractiveness Analysis, By Product, 2022 to 2032
Figure 87: South Asia Market Attractiveness Analysis, By Product, 2022 to 2032
Figure 88: India Market Value Proportion Analysis, 2021
Figure 89: Global Vs India Y-o-Y Growth Comparison, 2021 to 2032
Figure 90: India Market Share Analysis (%) by Product, 2021 to 2032
Figure 91: Indonesia Market Value Proportion Analysis, 2021
Figure 92: Global Vs Indonesia Y-o-Y Growth Comparison, 2021 to 2032
Figure 93: Indonesia Market Share Analysis (%) by Product, 2021 to 2032
Figure 94: Malaysia Market Value Proportion Analysis, 2021
Figure 95: Global Vs Malaysia Y-o-Y Growth Comparison, 2021 to 2032
Figure 96: Malaysia Market Share Analysis (%) by Product, 2021 to 2032
Figure 97: Thailand Market Value Proportion Analysis, 2021
Figure 98: Global Vs Thailand Y-o-Y Growth Comparison, 2021 to 2032
Figure 99: Thailand Market Share Analysis (%) by Product, 2021 to 2032
Figure 100: Philippines Market Value Proportion Analysis, 2021
Figure 101: Global Vs Philippines Y-o-Y Growth Comparison, 2021 to 2032
Figure 102: Philippines Market Share Analysis (%) by Product, 2021 to 2032
Figure 103: Vietnam Market Value Proportion Analysis, 2021
Figure 104: Global Vs Vietnam Y-o-Y Growth Comparison, 2021 to 2032
Figure 105: Vietnam Market Share Analysis (%) by Product, 2021 to 2032
Figure 106: Oceania Market Share, By Product, 2022 (E)
Figure 107: Oceania Market Share, By Country, 2022 (E)
Figure 108: Oceania Market Size (US$ Million) Analysis, 2012 to 2021
Figure 109: Oceania Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2032
Figure 110: Oceania Market Attractiveness Analysis, By Product, 2022 to 2032
Figure 111: Oceania Market Attractiveness Analysis, By Country, 2022 to 2032
Figure 112: Australia Market Value Proportion Analysis, 2021
Figure 113: Global Vs Australia Y-o-Y Growth Comparison, 2021 to 2032
Figure 114: Australia Market Share Analysis (%) by Product, 2021 to 2032
Figure 115: New Zealand Market Value Proportion Analysis, 2021
Figure 116: Global Vs New Zealand Y-o-Y Growth Comparison, 2021 to 2032
Figure 117: New Zealand Market Share Analysis (%) by Product, 2021 to 2032
Figure 118: Middle East & Africa Market Share, By Product, 2022 (E)
Figure 119: Middle East & Africa Market Share, By Country, 2022 (E)
Figure 120: Middle East & Africa Market Size (US$ Million) Analysis, 2012 to 2021
Figure 121: Middle East & Africa Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2032
Figure 122: Middle East & Africa Market Attractiveness Analysis, By Product, 2022 to 2032
Figure 123: Middle East & Africa Market Attractiveness Analysis, By Country, 2022 to 2032
Figure 124: GCC Countries Market Value Proportion Analysis, 2021
Figure 125: Global Vs GCC Countries Y-o-Y Growth Comparison, 2021 to 2032
Figure 126: GCC Countries Market Share Analysis (%) by Product, 2021 to 2032
Figure 127: Turkey Market Value Proportion Analysis, 2021
Figure 128: Global Vs Turkey Y-o-Y Growth Comparison, 2021 to 2032
Figure 129: Turkey Market Share Analysis (%) by Product, 2021 to 2032
Figure 130: Israel Market Value Proportion Analysis, 2021
Figure 131: Global Vs Israel Y-o-Y Growth Comparison, 2021 to 2032
Figure 132: Israel Market Share Analysis (%) by Product, 2021 to 2032
Figure 133: South Africa Market Value Proportion Analysis, 2021
Figure 134: Global Vs South Africa Y-o-Y Growth Comparison, 2021 to 2032
Figure 135: South Africa Market Share Analysis (%) by Product, 2021 to 2032
Figure 136: North Africa Market Value Proportion Analysis, 2021
Figure 137: Global Vs North Africa Y-o-Y Growth Comparison, 2021 to 2032
Figure 138: North Africa Market Share Analysis (%) by Product, 2021 to 2032
The global pneumonia diagnostics market size reached USD 492.2 Million in 2021 and is likely to touch a valuation of USD 521.1 Million in 2022.
The pneumonia diagnostics market is expected to reach USD 899.4 Million by the end of 2032, with sales revenue expected to grow at 5.6% CAGR throughout the forecast period.
Growing adoption by the increasing geriatric population, innovative product development, and increasing prevalence of infectious diseases are some of the key trends in this market.
The USA, Canada, China, Germany, and the UK are driving demand for pneumonia diagnostics products.
The USA accounted for about 84.0% of the North American pneumonia diagnostics market in 2021.
Demand for pneumonia diagnostics in Europe is expected to grow at 7.5% CAGR over the next ten years.
The USA, China, and Germany are the key producers of pneumonia diagnostics.
Thermo Fisher Scientific Inc., Alere Inc., Quidel Corporation, Becton, Dickinson and Company, Meridian Bioscience, Inc, Qiagen N.V., bioMérieux SA, Bio-Rad Laboratories Inc., Cardinal Health Inc., Beckman Coulter Inc (Danaher Corporation), Hologic Inc., La Roche Ltd., Abbot Laboratories, Quest Diagnostics, and Luminex Corporation are some of the key players in the pneumonia diagnostics industry.
The pneumonia diagnostics market in Japan is set to expand at a CAGR of 5.5% during the forecast years.
The overall pneumonia diagnostics market in China is set to expand at a CAGR of 6.4% during the forecast period.
Explore Similar Insights
Pneumonia Diagnostics Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
